Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC26A2 |
| Upstream (Parents) |
|---|
| (<<) CTSL2 → SLC26A2 |
| (<<) PLAGL2 → SLC26A2 |
| (<<) QPCT → SLC26A2 |
| (<<) PLCB4 → SLC26A2 |
| (<<) CKB → SLC26A2 |
| Downstream (Children) |
|---|
| SLC26A2 → QPCT (>>) |
| SLC26A2 → SEMA5A (>>) |
| SLC26A2 → GRM8 (>>) |
| SLC26A2 → HAVCR1 (>>) |
| SLC26A2 → AQP8 (>>) |
| SLC26A2 → LOC100131795///NMNAT2 (>>) |
| SLC26A2 → TNMD (>>) |
| SLC26A2 → ACE2 (>>) |
| SLC26A2 → CKB (>>) |
| SLC26A2 → GABRA2 (>>) |
| SLC26A2 → H2AFY2 (>>) |
| SLC26A2 → GOLIM4 (>>) |
| SLC26A2 → BAIAP2 (>>) |
